Hospital Pharmacists from around the world belong to the Hospital Pharmacy Section of FIP. We focus on education, communication and improving the practice of pharmacy in hospitals around the world.
The members of the Hospital Pharmacy Section share experiences and discuss issues affecting the practice of pharmacy and health care in the hospital setting. We identify the global issues that require attention and work together to develop guidelines and standards of practice.
The members of the Hospital Pharmacy Section meet yearly at the FIP Congress where personal and professional connections are made, and ideas shared. Notably, The Global Conference on the Future of Hospital Pharmacy was hosted by the Hospital Pharmacy Section as part of the 68th Annual Congress. A total of 348 hospital pharmacists representing 98 nations met in Basel, Switzerland on 30 and 31 August and successfully developed consensus statements reflecting the profession’s preferred vision of practice in the hospital setting. Yet, sharing and educating our colleagues goes well beyond this one annual event. With that in mind, grounded in the Basel Statements, the FIP Hospital Pharmacy Section is pleased to announce three (3) webinars to meet the interests and educational needs of our members.
Enhance your skills, confidence and ability to better serve patients in health-systems around the world.
Topic 1: Counterfeit Medications
Date/Time: September 29th 2016/ 8 am EST (US)
Description: Substandard, spurious, falsely labelled, falsified and counterfeit (SSFFC) medical products or “counterfeit medications” are defined as those that contain the wrong or no active ingredient or are contaminated. They are becoming increasingly common within supply chains worldwide and pose a serious risk to patient safety. This webinar will provide an overview of the SSFFC issues as well as outline current surveillance and monitoring programs employed globally to combat this public health issue.
Related Basel Statements:
• 3. Hospital pharmacists should engage health authorities and hospital administrators to ensure appropriate resources for, and design of, the hospital medicines-use process.
• 20. Hospital pharmacists should be involved in the complex process of procurement of medicines and health products, promoting equity and access. They should ensure transparent procurement processes are in place in line with best practice and national legislation, are free from conflict of interest, and are based on the principles of safety, quality and efficacy.
• 49. An easily accessible reporting system for defective medicines should be established and maintained. Reports of defective or substandard medicines should be reviewed internally and sent in a timely manner to regional or national pharmacovigilance or regulatory reporting programs, and the manufacturer.
Presenter(s): Libby Baney, J.D. Executive Director, Alliance for Safe Online Pharmacies, Nkechi Christiana Anyanwu, Federal Medical Centre, Nigeria
Topic 2: Medication Safety Best Practices
Date/Time: November 15th 2016 / 7 am EST (US)
Description: As health care practitioners, it is imminent that pharmacists provide care for patients that is both effective and safe. This learning opportunity outlines global best practices for ensuring patient safety and technological advances that can augment our efforts.
Related Basel Statements:
• 8. Hospital pharmacists should monitor patients taking medicines to assure patient safety, appropriate medicine use, and optimal outcomes for inpatients and outpatients. When resource limitations do not permit pharmacist monitoring of all patients taking medicines, patient selection criteria should be established to guide pharmacist monitoring.
• 39. Hospital pharmacists should develop simple, rules-based approaches to advancing patient safety; for example, when a large number of dosage units are needed to give a dose (more than two tablets, vials, etc.), the prescription should be verified prior to preparation or dispensing.
• 40. Hospital pharmacists should ensure that the information resources needed for safe medicines preparation and administration are accessible at the point of care.
• 46. Hospital pharmacists should develop and implement policies and practices that prevent route errors.
• 51. An easily accessible, non-punitive reporting system for medication errors, including near misses, should be established and maintained. Reports of medication errors should be reviewed internally and sent to regional or national medication error reporting or regulatory programs. These data should be regularly reviewed to improve the quality and safety of medicines use practices.
Presenter(s): John B. Hertig: Purdue University, United States, Abdul Latif Sheikh: President, Society of Hospital Pharmacists of Pakistan, Jacqueline Surugue: Past President of FIP Hospital Section
Topic 3: Poster and Abstract Preparation
Date/Time: January 17th 2017/ 7 am EST (US)
Description: Adding to the collective global knowledge available to pharmacists is one of the most important contributions we can make. While the process of preparing formal posters and presentations can be time-intensive, sharing knowledge is an integral part of advancing the practice of pharmacy worldwide. Learn more about the abstract preparation and submission process as well as specific requirements for publications submitted to FIP.
Presenter(s): Rebekah Moles: Senior Lecturer, Faculty of Pharmacy, University of Sydney, and Ryan A. Forrey: Director of Pharmacy, Emory University Hospital Midtown
For further information: http://us9.campaign-archive2.com/?u=8a53014ef869b0c219eac7e5f&id=711763291d&e=f318fa18a0